LFVN Stock Risk & Deep Value Analysis
LifeVantage Corp
Consumer Defensive • Packaged Foods
DVR Score
out of 10
What You Need to Know About LFVN Stock
We analyzed LifeVantage Corp using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran LFVN through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
How Risky Is LFVN Stock?
Overall Risk
Aggressive
Financial Risk
High
Market Risk
Medium
Competitive Risk
High
Execution Risk
High
Regulatory Risk
High
What Are the Red Flags for LFVN?
- ⚠
Q3 FY2026 earnings miss or weak forward guidance
- ⚠
Increased regulatory scrutiny on direct-selling models or supplement claims
- ⚠
Key executive departure or failure to attract critical digital talent
- ⚠
Intensified competitive pressure from larger wellness brands
Unlock LFVN Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does LifeVantage Corp (LFVN) Do?
Market Cap
$81.67M
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
232
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre- and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
Visit LifeVantage Corp WebsiteIs LFVN Stock Undervalued?
Unlock the full AI analysis for LFVN
Get the complete DVR score, risk analysis, and more
Is LFVN Financially Healthy?
P/E Ratio
8.24
Does LFVN Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Stable
Moat Sources
2 Identified
The company's intellectual property in nutrigenomics, particularly its Protandim product line, provides a narrow moat. This scientific differentiation, if continuously reinforced by research and effective marketing, can sustain a loyal customer base. However, the direct-selling model inherently limits broader brand reach and is vulnerable to shifts in consumer trust and regulatory environments.
Moat Erosion Risks
- •Competitors introducing similar or superior nutrigenomic products
- •Regulatory challenges impacting direct selling or specific product claims
- •Brand dilution or reputational damage from continued reliance on the MLM model without significant digital-first overhaul
LFVN Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive LFVN Stock Higher?
Near-Term (0-6 months)
- •Estimated Q3 FY2026 Earnings (typically early May 2026)
- •New digital platform feature rollout & user adoption metrics
- •Targeted product launches under new digital strategy
Medium-Term (6-18 months)
- •Expanded international digital market penetration
- •Strategic partnership announcement with health/tech influencers or e-commerce platforms
- •Sustained positive cash flow generation
Long-Term (18+ months)
- •Successful brand re-positioning as a leading digital nutrigenomics company
- •Significant market share gain in the wellness supplement sector
- •Successful acquisition of complementary digital health assets
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for LFVN?
- ✓
Acceleration in digital sales revenue and growth in new, non-distributor customer accounts
- ✓
Significant improvements in customer retention rates and average order value
- ✓
Consistent positive commentary from management regarding the success and scalability of the digital pivot
- ✓
Evidence of institutional investor accumulation and positive analyst sentiment shifts
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for LFVN (LifeVantage Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
